New research may pave the way for treatment of vaginal yeast infections

New research could one day pave the way for the treatment of vaginal yeast infections, by shedding new light on how microbes in the body absorb zinc.

Glenmark, Alphamab deal worth up to $700M; Tourmaline’s $150M offering; Repare records $40M milestone

Plus, news about Vera Therapeutics and Cellectar Biosciences: Alphamab Oncology, Glenmark ink licensing deal: Per the agreement, Glenmark will spend up to $700.8 million in

January 26, 2024

Why is eugenics still alive and well in scientific publishing?

While the bogus science of eugenics — the idea that the human race can be improved through selective reproduction — has been nearly universally discredited,

July 3, 2024

Alzheimer’s Onset Delayed by Rare Mutation

One copy of the APOE3 Christchurch variant delayed onset of autosomal dominant Alzheimer’s disease. Mild cognitive impairment occurred 5 years later than expected in people

June 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.